Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increased pet humanization
3.2.1.2 Rising cancer incidence in pets
3.2.1.3 Advancements in veterinary oncology diagnosis and treatment
3.2.1.4 Growing awareness and diagnostic capabilities
3.2.2 Industry pitfalls and challenges
3.2.2.1 High treatment costs
3.2.2.2 Side effects and animal tolerance
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Species, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Dogs
5.3 Cats
5.4 Other species
Chapter 6 Market Estimates and Forecast, By Therapy, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Chemotherapy
6.3 Immunotherapy
6.4 Targeted therapy
6.5 Combination therapy
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Oral
7.3 Injection
Chapter 8 Market Estimates and Forecast, By Cancer Type, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 Lymphoma
8.3 Mast cell cancer
8.4 Melanoma
8.5 Mammary and squamous cell cancer
8.6 Other cancer types
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 AB Science
10.2 Boehringer Ingelheim International
10.3 CureLab Oncology
10.4 Dechra Pharmaceuticals
10.5 Elanco Animal Health
10.6 ELIAS Animal Health
10.7 NovaVive
10.8 Qbiotics
10.9 Pfizer
10.10 Torigen
10.11 Vibrac
10.12 Vivesto
10.13 Zoetis
